Amy Abernethy, M.D., Ph.D. joins insitro Board of Directors

insitro, a machine learning-powered drug discovery and development company, today announced that Amy Abernethy, M.D., Ph.D, has joined the company’s board of directors. Dr. Abernethy, who has dedicated her career to transforming clinical development to drive innovation for patients, brings deep expertise having held a number of leadership roles in...

The post Amy Abernethy, M.D., Ph.D. joins insitro Board of Directors first appeared on AI-TechPark.

ai learning ai ml aitech news amy board board of directors career clinical deep learning deep learning computer development discovery drive drug discovery drug discovery and development expertise her innovation joins leadership machine machine learning machine learning computer machine learning in action machine learning in supply chain machine learning server patients roles the company